Press Releases
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for J& J’s Lead COVID-19 Vaccine
Emergent BioSolutions Inc. announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for...
News
Omya completes expansion of Orgon production plant
Omya has rebuiltand expanded its calcium carbonate production plant in Orgon, France, creating a substantially higher capacity for its functionalized calcium carbonate product platform,...
Press Releases
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
Mylan N.V. announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as...
Press Releases
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the U.S. FDA granted Emergency Use Authorization (EUA) for a rapid,...
Drug Research
Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market
With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal...
Clinical Trials
QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19
QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment...
Drug Research
CIRION BioPharma Research Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing Services
CIRION Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced that the company is now offering new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read